Professor Thomas Borody Interview Part 2
In the second part of our interview with the esteemed Professor Thomas Borody from Australia, we discuss the question of ethical clinical trials, the progress in Australia with the Ivermectinbased tritherapy he recommends for COVID19, the role of State and federal authories. The interview also includes a message to Canada and other countries that deny early treatment to the population and the critical importance of the doctor patient relationship and the right for medical doctors to prescribe offlabel. Its important to realize that Professor Borodys stance is contrary to the mainstream when it comes to therapeutics for COVID19.
|
|